About this Research Topic
In view of this, it is clear that tumor progression and response to treatment is due to the interplay of these different components and that the combination of therapies targeting different factors is likely to have major clinical efficacy. In this scenario, the role of the microbiota is still not completely investigated and its physiological interaction with the TME should be considered.
The need to find new ways to explore and describe this complexity has prompted this Research Topic, with the aim to bring together novel discoveries that shed light on the molecular pathways and cellular processes involved in TME-cancer crosstalk at the signaling level, and to reveal how these networks can modulate cancer progression and response to treatments.
We specifically welcome Original Research or Review articles that address the following aspects:
- TME-cancer crosstalk, cancer progression and drug resistance
- Cell-cell communication networks in TME
- Cancer signaling networks in TME
- Microbiota signaling in TME
- Noncoding RNA, the TME and microbiota interaction
- Role of the TME and gut microbiome in drug resistance
- Metabolic communication between tumor cells and TME
- Neural regulation of TME
- Organoid models of TME
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: tumor microenvironment, signaling networks, microbiota, cell communication
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.